Braskem S.A. (BAK)
| Bid | 3.5 |
| Market Cap | 1.46B |
| Revenue (ttm) | 77.41B |
| Net Income (ttm) | -11.32B |
| EPS (ttm) | -4.8 |
| PE Ratio (ttm) | -0.74 |
| Forward PE | 1.55 |
| Analyst | Buy |
| Ask | 3.65 |
| Volume | 265,809 |
| Avg. Volume (20D) | 828,411 |
| Open | 3.78 |
| Previous Close | 3.68 |
| Day's Range | 3.52 - 3.79 |
| 52-Week Range | 2.85 - 8.09 |
| Beta | 0.92 |
About BAK
Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including ethylene, polymer and chemical grade propylene, butadiene, butene-1, benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tert...
Analyst Forecast
According to 3 analyst ratings, the average rating for BAK stock is "Buy." The 12-month stock price forecast is $9.75, which is an increase of 176.20% from the latest price.
Stock Forecasts
1 month ago · seekingalpha.com
Braskem Q4: Challenging But Opportune Scenario For Patient InvestorsBraskem's net revenues fell 14% q/q and 2% y/y in 4Q24 due to reduced petrochemical spreads and lower demand. Despite high leverage, Braskem's $2.4 billion cash ensures debt coverage for the next 47 m...
